Table 3 Anthropometric and cardiometabolic risk indicators according to the Sex-specific thresholds of the fat-to-muscle ratio
From: The association between fat-to-muscle ratio and metabolic disorders in type 2 diabetes
Variable | Low-FMR group (n = 109) | High-FMR group (n = 252) | P value |
|---|---|---|---|
Weight (kg) | 58.5 ± 9.8 | 70.1 ± 11.6 | < 0.001 |
BMI (kg/m2) | 21.3 ± 2.5 | 26.1 ± 3.2 | < 0.001 |
Waist circumference (cm) | 84.2 ± 8.3 | 95.4 ± 8.8 | < 0.001 |
Fat mass (kg) | 11.6 ± 3.8 | 20.9 ± 5.4 | < 0.001 |
Muscle mass (kg) | 43.4 ± 8.2 | 45.2 ± 8.2 | 0.059 |
Body fat percentage (%) | 19.9 ± 6.1 | 29.8 ± 5.2 | < 0.001 |
Systolic blood pressure (mmHg) | 127.1 ± 17.0 | 132.9 ± 19.6 | 0.005 |
Diastolic blood pressure (mmHg) | 75.0 ± 10.7 | 77.9 ± 12.5 | 0.039 |
Total cholesterol (mmol/L) | 4.9 ± 1.3 | 5.1 ± 1.5 | 0.212 |
Triglycerides (mmol/L) | 1.2 (0.9–1.8) | 1.9 (1.3–2.9) | < 0.001 |
HDL-cholesterol (mmol/L) | 1.2 ± 0.3 | 1.0 ± 0.3 | < 0.001 |
LDL-cholesterol (mmol/L) | 2.9 ± 1.0 | 3.0 ± 1.0 | 0.594 |
TG/HDL ratio | 1.0 (0.7–1.7) | 1.8 (1.1–3.1) | < 0.001 |
HOMA2-IR | 1.8 ± 1.1 | 2.6 ± 1.5 | < 0.001 |
Hypertension (n, %) | 43 (39.4%) | 176 (69.8%) | < 0.001 |
Fatty liver disease (n, %) | 39 (36.8%) | 179 (74.6%) | < 0.001 |
Abdominal obesity (n, %) | 37 (33.9%) | 210 (83.3%) | < 0.001 |
Hypertriglyceridemia (n, %) | 31 (28.4%) | 145 (57.5%) | < 0.001 |
Low HDL-cholesterol (n, %) | 33 (30.3%) | 142 (56.3%) | < 0.001 |
Metabolic syndrome (n, %) | 41 (37.6%) | 219 (86.9%) | < 0.001 |